Jan 28 (Reuters) - Elon Musk's brain implant company Neuralink said on Wednesday it now has 21 total participants enrolled in ...

Elon Musk's Neuralink prepares Blindsight implant human trials by 2026, aiming to restore vision for the blind with FDA Breakthrough Device Designation.

Elon Musk's Neuralink has expanded its human trials to 21 participants and plans to launch a next-generation brain implant with three times the current capabilities later this year, including a future ...

Neuralink is preparing to begin its first human clinical trials of the Blindsight implant in 2026, which aims to restore vision for people with complete blindness.Neuralink Founder Elon Musk ...

Tech billionaire Elon Musk announced the next-gen Neuralink chips. Plus, first trials for Blindsight augmentation are also on their way.

Elon Musk's Neuralink is set to release a next-generation cybernetic augment with triple the capability, expected later this year. The company is also preparing its first blindsight augment, which ...

Neuralink expands trials to 21, advancing brain implants for paralysis and unveiling new cybernetic and Blindsight enhancements.

Elon Musk’s brain implant company Neuralink aims to implant its chips in 20,000 people annually by 2031, potentially generating over $1 billion in yearly revenue, according to documents reviewed by ...

Sebastian Gomez Pena, a medical student, described his experience with Elon Musk’s Neuralink brain chip as transformative.